Liver cancer - Latest research and news | Nature
Dec 30, 2024 · In 2024, important studies highlighted the ongoing global battle against liver cancer, a deadly yet common cancer. Despite advances in treatments, obstacles persist in early detection and equity ...
Hepatocellular carcinoma - Latest research and news | Nature
Jan 7, 2025 · In 2024, important studies highlighted the ongoing global battle against liver cancer, a deadly yet common cancer. Despite advances in treatments, obstacles persist in early detection and equity ...
A new treatment combination for liver cancer - Nature
Jul 22, 2021 · Treatment options are limited for patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer. The multi-kinase inhibitor lenvatinib is used in this setting, but ...
Transforming the landscape of liver cancer detection and care
Nov 18, 2024 · In 2024, important studies highlighted the ongoing global battle against liver cancer, a deadly yet common cancer. Despite advances in treatments, obstacles persist in early detection and equity ...
Liver cancer | Nature Reviews Gastroenterology & Hepatology
Nov 18, 2024 · In 2024, important studies highlighted the ongoing global battle against liver cancer, a deadly yet common cancer. Despite advances in treatments, obstacles persist in early detection and equity ...
Lethal lipotoxicity for liver cancer therapy - Nature Cancer
Feb 15, 2021 · In this issue of Nature Cancer, Rudalska et al. demonstrate that combined inhibition of the serine–threonine kinase Raf-1 and activation of liver X receptor-α (LXRα) triggers lethal ...
Liver cancer articles within British Journal of Cancer - Nature
Jul 6, 2024 · Read the latest Research articles in Liver cancer from British Journal of Cancer
Liver diseases - Latest research and news | Nature
In 2024, important studies highlighted the ongoing global battle against liver cancer, a deadly yet common cancer. Despite advances in treatments, obstacles persist in early detection and equity ...
Exploiting liver metabolism for tissue-specific cancer targeting
Mar 28, 2023 · Chemical screening now identifies YC-1 as a tissue-specific anti-cancer compound that is activated in the liver by the sulfotransferase enzyme SULT1A1.
Joining the dots for better liver cancer treatment - Nature
Nov 11, 2019 · Powerful single-cell analyses discover rare cellular sub-populations and complex cell–cell interactions at an unprecedented level, which could help to solve key questions in liver biology and ...